MENU
ETNB
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

89bio (ETNB) Earnings Date & Reports

89bio Inc is a United States-based clinical-stage biopharmaceutical company focused on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases... Show more

A.I. Advisor
published Earnings

ETNB is expected to report earnings to fall 26.18% to -52 cents per share on November 06

89bio ETNB Stock Earnings Reports
Q3'25
Est.
$-0.52
Q2'25
Missed
by $0.21
Q1'25
Beat
by $0.03
Q4'24
Missed
by $0.27
Q3'24
Missed
by $0.77
The last earnings report on August 07 showed earnings per share of -70 cents, missing the estimate of -50 cents. With 1.78M shares outstanding, the current market capitalization sits at 1.32B.
View a ticker or compare two or three
ETNB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ETNB showed earnings on August 07, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of innovative therapies for nonalcoholic steatohepatitis (NASH), liver and cardio-metabolic diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
142 Sansome Street
Phone
+1 415 432-9270
Employees
70
Web
https://www.89bio.com